Suven Life Sciences - Quaterly Results

25 Oct 2021 Evaluate
The Sales for the quarter ended September 2021 of Rs. 11.84 million declined by -86.82% from Rs. 89.80 millions.The Net Loss for the quarter ended September 2021 is Rs. -109.83 millions as compared to Net Loss of Rs. -19.00 millions of corresponding quarter ended September 2020 Operating profit Margin for the quarter ended September 2021 further decreased to -97.99% as compared to -15.67% of corresponding quarter ended September 2020


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 11.84 89.80 -86.82 31.90 104.09 -69.35 134.78 144.15 -6.50
Other Income 5.03 22.77 -77.91 50.58 48.06 5.24 77.54 140.36 -44.76
PBIDT -97.99 -15.67 525.34 -171.05 -68.52 149.64 -227.93 -212.80 7.11
Interest 1.50 2.53 -40.71 3.03 4.48 -32.37 8.15 4.87 67.35
PBDT -99.49 -18.20 446.65 -174.08 -73.00 138.47 -236.08 -217.67 8.46
Depreciation 10.34 10.75 -3.81 20.68 21.40 -3.36 43.46 41.69 4.25
PBT -109.83 -28.95 279.38 -194.76 -94.40 106.31 -279.54 -259.36 7.78
TAX 0.00 -9.95 0.00 0.00 -34.62 0.00 -53.23 -121.83 -56.31
Deferred Tax 0.00 -9.95 0.00 0.00 -34.62 0.00 -53.23 -141.55 -62.39
PAT -109.83 -19.00 478.05 -194.76 -59.78 225.79 -226.31 -137.53 64.55
Equity 127.28 127.28 0.00 127.28 127.28 0.00 127.28 127.28 0.00
PBIDTM(%) -827.62 -17.45 4642.82 -536.21 -65.83 714.56 -169.11 -147.62 14.56

Suven Life Sciences Share Price

165.70 0.55 (0.33%)
02-Jan-2026 10:17 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1726.70
Dr. Reddys Lab 1246.90
Cipla 1507.65
Zydus Lifesciences 914.10
Lupin 2106.95
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×